Kestra Medical Technologies, Ltd.
KMTS
$24.83
-$0.38-1.51%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.95% | 50.39% | -142.01% | -5.60% | -2.43% |
| Total Depreciation and Amortization | 17.01% | 10.46% | -2.75% | 1.02% | -21.31% |
| Total Amortization of Deferred Charges | -0.21% | 27.10% | 117.06% | -74.28% | 230.50% |
| Total Other Non-Cash Items | 258.70% | -89.75% | 3,036.55% | -60.60% | 91.53% |
| Change in Net Operating Assets | 111.89% | -72.86% | -2,913.01% | 104.71% | -81.40% |
| Cash from Operations | 30.19% | -10.87% | -28.91% | -1.82% | -3.18% |
| Capital Expenditure | 9.30% | -2.80% | -97.98% | 12.13% | 34.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 116.22% | -86.93% | -- | -- | 786.96% |
| Cash from Investing | 9.86% | -6.07% | -91.02% | 8.08% | 37.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.56% | 45.81% | -2,807.56% | 79.30% | -104.47% |
| Cash from Financing | 98.56% | -100.87% | 180,522.69% | 79.30% | -100.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.11% | -119.85% | 912.03% | 2.10% | -125.13% |